01 Aug 2025
// PR NEWSWIRE
11 Jun 2025
// FDA
03 Feb 2025
// FDA
Latest Content by PharmaCompass
Digital content
01 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/zenara-pharma-receives-us-fda-approval--for-first-generic-of-sertraline-hydrochloride-capsules-with-180-day-cgt-exclusivity-302519297.html
11 Jun 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218797
03 Feb 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214844
21 Aug 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218205
05 Aug 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218169
15 May 2023
// HEALTH ET
https://health.economictimes.indiatimes.com/news/pharma/drug-approvals-launches/biophore-its-subsidiary-zenara-pharma-receive-first-approval-for-cannabidiol-in-india/100251790